Viral pneumonia
MONDO:0006012Inflammation of the lung parenchyma that is caused by a viral infection.
Also known as: Viruses caused pneumonia, Viruses pneumonia
89 clinical trials for this condition and its sub-types, 27 tagged with Viral pneumonia itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Viral pneumonia
-
Cytomegalovirus pneumonia 0 trials
1 sub-type
-
Can an updated COVID-19 vaccine keep up with the virus?
Vaccine Recruiting nowThis trial is testing an updated version of the BNT162b2 COVID-19 vaccine in healthy adults aged 18 to 64. Participants will receive either the updated COVID-19 vaccine or a Tdap vaccine (for tetanus, diphtheria, and whooping cough) to compare safety and measure spike protein lev…
Phase 4 • Sponsor: BioNTech SE • Aim: Vaccine
Last updated Aug 09, 2026 00:00 UTC
-
New drug aims to save lives in severe viral lung infections
Disease control Recruiting nowThis large Phase 3 trial is testing an experimental drug called tozorakimab in about 2,870 adults hospitalized with a viral lung infection who need extra oxygen. Participants receive either a single dose of tozorakimab or a placebo, added to standard care. The main goal is to see…
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New pill combo aims to protect vulnerable from severe COVID
Disease control Recruiting nowThis phase 3 trial tests a new antiviral pill, ibuzatrelvir, alone or with an IV drug (remdesivir) in 300 adults with weak immune systems who have mild-to-moderate COVID-19. The goal is to see if the combination prevents hospitalizations or worsening symptoms better than remdesiv…
Phase 3 • Sponsor: Pfizer • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
New pill aims to keep High-Risk COVID patients out of the hospital
Disease control Recruiting nowThis study tests an oral medication called ibuzatrelvir in adults and teens with COVID-19 who are not hospitalized but have a high risk of becoming severely ill. Participants will receive either the drug or a placebo for 5 days, and researchers will track whether it reduces emerg…
Phase 3 • Sponsor: Pfizer • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Could a cold sore virus treatment save ICU pneumonia patients?
Disease control Recruiting nowThis study tests whether the antiviral drug acyclovir helps people on breathing machines who have pneumonia and also have herpes simplex virus (HSV) in their lungs. About 616 adults in intensive care will be randomly assigned to receive acyclovir or no antiviral treatment. The go…
Phase 3 • Sponsor: Jena University Hospital • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Experimental 'Storm Stopper' therapy tested for COVID-19, flu, and RSV
Disease control Recruiting nowThis early-stage trial tests a new drug called PRS CK STORM, made from a mix of immune and fat cells, to see if it can safely calm the 'cytokine storm'—a dangerous overreaction of the immune system—in people with severe lung infections from COVID-19, flu, or RSV. The study will e…
Phase 1/2 • Sponsor: PEACHES BIOTECH • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New drug AV-001 aims to help hospitalized pneumonia patients breathe easier
Disease control Recruiting nowThis study tests a new drug called AV-001 in 120 hospitalized adults with pneumonia who need extra oxygen. The drug is given daily for up to 28 days alongside standard care. The goal is to see if it is safe and helps patients recover faster from pneumonia caused by COVID-19 or ot…
Phase 2 • Sponsor: Vasomune Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New score could help doctors spot fungal pneumonia faster
Diagnosis Recruiting nowThis study aims to create and test a clinical prediction score called FUNGAL-P to help doctors identify fungal pneumonia early in adults who come to the hospital with pneumonia. Researchers will analyze medical records from past patients and then test the score on new patients to…
Sponsor: Azienda Ospedaliero-Universitaria Careggi • Aim: Diagnosis
Last updated Jul 04, 2026 00:00 UTC